ROSA CANETE-YOHAM: Open Payments
NPI 1831587286 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,590 in 153 payments from 24 companies in 2025. Trend: 2023 $583 · 2024 $2,856 · 2025 $3,590
Food & beverage: $3,584Education: $6
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $568 |
| AstraZeneca Pharmaceuticals LP | 15 | $410 |
| United Therapeutics Corporation | 13 | $338 |
| GENZYME CORPORATION | 12 | $303 |
| Insmed, Inc. | 16 | $264 |
| Baxter Healthcare | 11 | $255 |
| ANI Pharmaceuticals, Inc. | 6 | $175 |
| Regeneron Healthcare Solutions, Inc. | 10 | $157 |
| Electromed, Inc. | 7 | $154 |
| Verona Pharma, Inc. | 7 | $150 |
Products named: NUCALA, DUPIXENT, Tyvaso, Arikayce, Hillrom - Vest System Model 105 Home Care, PURIFIED CORTROPHIN GEL, BREZTRI, SMARTVEST.
Industry payments across FL — which companies pay providers there.
